Quick Answer
PLUS THERAPEUTICS, INC. reported Stockholders Equity of $4.00 million for fiscal year 2025.
PLUS THERAPEUTICS, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $4.00M | +144.7% |
| 2024 | -$8.95M | -563.9% |
| 2023 | -$1.35M | -120.9% |
| 2022 | $6.45M | -40.5% |
| 2021 | $10.84M | +257.5% |
| 2020 | $3.03M | +161.3% |
| 2019 | $1.16M | -77.8% |
| 2018 | $5.22M | -59.8% |
| 2017 | $13.00M | +18.3% |
| 2016 | $10.99M | -10.0% |
| 2015 | $12.21M | +314.1% |
| 2014 | -$5.70M | -282.1% |
| 2013 | $3.13M | -51.5% |
| 2012 | $6.46M | -35.1% |
| 2011 | $9.95M | -56.5% |
| 2010 | $22.87M | +725.3% |
| 2009 | -$3.66M | +52.6% |
| 2008 | -$7.72M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $5.05M | +197.7% | +66.6% |
| June 30, 2025 | $3.03M | +139.8% | +112.8% |
| March 31, 2025 | -$23.64M | -388.8% | -164.2% |
| December 31, 2024 | -$8.95M | -563.9% | -73.0% |
| September 30, 2024 | -$5.17M | -297.3% | +32.1% |
| June 30, 2024 | -$7.62M | -386.4% | -57.6% |
| March 31, 2024 | -$4.84M | -280.8% | -258.8% |
| December 31, 2023 | -$1.35M | -120.9% | -151.4% |
- PLUS THERAPEUTICS, INC. showed an increase of +144.7% in Stockholders Equity compared to the prior fiscal year.
- Over the 2008–2025 period, PLUS THERAPEUTICS, INC.’s stockholders equity has grown by 151.8% (from -$7.72 million to $4.00 million).
- The most recent figure is from PLUS THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: